Asset Details
Do you wish to reserve the book?
Steroid withdrawal after renal transplantation: a retrospective cohort study
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Steroid withdrawal after renal transplantation: a retrospective cohort study
Do you wish to request the book?
Steroid withdrawal after renal transplantation: a retrospective cohort study
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Steroid withdrawal after renal transplantation: a retrospective cohort study
2017
Overview
Background
Immunosuppressive regimens in renal transplantation frequently contain corticosteroids, but many centers withdraw steroids as a consequence of unwanted side effects of steroids. The optimal timing to withdraw steroids after transplantation, however, remains unclear. The aim of this study was to determine an optimal time point following kidney transplantation that is associated with reduced mortality without jeopardizing the allograft to allow safe discontinuation of steroids.
Methods
We conducted a retrospective cohort study and computed a concatenated landmark-stratified Cox supermodel to estimate hazard ratios and 95% confidence intervals for mortality and graft loss using dynamic propensity score matching to adjust for confounding by indication.
Results
A total of 6070 first kidney transplant recipients in the Austrian Dialysis and Transplant Registry who were transplanted between 1990 and 2012 were evaluated and classified according to steroid treatment status throughout follow-up after kidney transplantation; 2142 patients were withdrawn from steroids during the study period. Overall, 1131 patients lost their graft and 821 patients in the study cohort died. Steroid withdrawal within 18 months after transplantation was associated with an increased rate of graft loss compared to steroid maintenance during that time (6 months after transplantation: HR = 1.8; 95% CI, 1.3 to 2.6; 18 months after transplantation: HR = 1.3; 95% CI, 1.1 to 1.6; 24 months after transplantation: HR = 1.2; 95% CI, 0.9 to 1.5), while mortality was not different between groups.
Conclusions
Our findings suggest that steroid withdrawal after anti-IL-2 induction in the first 18 months after transplantation is associated with an increased risk of allograft loss.
Publisher
BioMed Central,BioMed Central Ltd,Springer Nature B.V
Subject
/ Austria
/ Biopsy
/ Complications and side effects
/ Female
/ Graft Rejection - prevention & control
/ Humans
/ Immunosuppressive Agents - administration & dosage
/ Immunosuppressive Agents - adverse effects
/ Kidney Transplantation - statistics & numerical data
/ Male
/ Medicine
/ Patients
/ Steroids
/ Steroids - administration & dosage
/ Substance Withdrawal Syndrome - epidemiology
/ Toxicity
